Poly(ethylene glycol)-modified proteins: implications for poly(lactide-co-glycolide)-based microsphere delivery.
about
Endothelial delivery of antioxidant enzymes loaded into non-polymeric magnetic nanoparticlesAnti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization.Unique insights into the intestinal absorption, transit, and subsequent biodistribution of polymer-derived microspheresPEGylated apoptotic protein-loaded PLGA microspheres for cancer therapy.Prevention of benzyl alcohol-induced aggregation of chymotrypsinogen by PEGylation.CXCL1 microspheres: a novel tool to stimulate arteriogenesis.Glycosylation improves α-chymotrypsin stability upon encapsulation in poly(lactic-co-glycolic)acid microspheresInjectable protease-operated depots of glucagon-like peptide-1 provide extended and tunable glucose control.Materials for pharmaceutical dosage forms: molecular pharmaceutics and controlled release drug delivery aspectsThe importance of interfaces in protein drug delivery - why is protein adsorption of interest in pharmaceutical formulations?Targeted delivery of Epirubicin to cancer cells by PEGylated A10 aptamer.Formulation of sustained-release microspheres of granulocyte macrophage colony stimulating factor by freezing-induced phase separation with dextran and encapsulation with blended polymers.Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier.A depot-forming glucagon-like peptide-1 fusion protein reduces blood glucose for five days with a single injection.
P2860
Q34036771-500FF6E7-0A21-4B61-BAF2-F5613FED55BFQ34473329-95ABBC38-D8F3-4C14-93AB-47E5C065E333Q34901313-62926E29-92F1-4059-A085-B39D66966D14Q35006422-183ABA8E-D392-4EB9-9A9F-FE8D84900D44Q35062556-9F0FD014-E591-4AA1-A96A-88B0EEB46EB5Q35864800-98389C77-9FB4-4D8E-A29F-E78BAE27B1F1Q36610259-D21BB1EB-CC6F-44B8-AD9A-1DA813EC8379Q36637567-57462655-0EF1-4291-B778-6FC738CC3A0DQ37801284-43BDDA09-062F-4027-9194-0AC117A903ABQ37873947-BE4B2826-E3D6-42E3-84D6-E4D708F8C3A5Q39132440-A02D307C-F256-4DB8-A30C-B6E1D3DAF0F8Q39463985-84A78176-42AB-405F-BFE9-A5C742626F7AQ42153590-DA5A540D-2644-46D2-94AE-72A10E9F0207Q42280003-04B4FC21-D331-466F-98E9-0E746D871CC2
P2860
Poly(ethylene glycol)-modified proteins: implications for poly(lactide-co-glycolide)-based microsphere delivery.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Poly(ethylene glycol)-modified ...... e)-based microsphere delivery.
@en
type
label
Poly(ethylene glycol)-modified ...... e)-based microsphere delivery.
@en
prefLabel
Poly(ethylene glycol)-modified ...... e)-based microsphere delivery.
@en
P2860
P1433
P1476
Poly(ethylene glycol)-modified ...... de)-based microsphere delivery
@en
P2093
Sheetal S Pai
Todd M Przybycien
P2860
P2888
P356
10.1208/S12248-009-9081-8
P407
P577
2009-02-06T00:00:00Z
P5875
P6179
1021701543